1. Home
  2. HRZN vs XOMA Comparison

HRZN vs XOMA Comparison

Compare HRZN & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Technology Finance Corporation

HRZN

Horizon Technology Finance Corporation

HOLD

Current Price

$6.69

Market Cap

275.7M

Sector

Finance

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$29.87

Market Cap

322.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRZN
XOMA
Founded
2008
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.7M
322.7M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
HRZN
XOMA
Price
$6.69
$29.87
Analyst Decision
Hold
Strong Buy
Analyst Count
4
4
Target Price
$7.13
$63.25
AVG Volume (30 Days)
739.7K
371.9K
Earning Date
10-28-2025
11-12-2025
Dividend Yield
19.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.82
Revenue
$98,899,000.00
$47,106,000.00
Revenue This Year
$3.03
$77.29
Revenue Next Year
$10.24
$34.91
P/E Ratio
N/A
$36.42
Revenue Growth
N/A
118.02
52 Week Low
$5.71
$18.35
52 Week High
$9.99
$39.92

Technical Indicators

Market Signals
Indicator
HRZN
XOMA
Relative Strength Index (RSI) 58.69 57.12
Support Level $6.49 $25.30
Resistance Level $6.38 $28.61
Average True Range (ATR) 0.13 1.58
MACD 0.03 0.66
Stochastic Oscillator 94.68 83.53

Price Performance

Historical Comparison
HRZN
XOMA

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: